Featured this week: 

• Jonathan Davick, MD
• Di Hu, PhD
• Hui Li, PhD
• Hong Lin, BS
• Jia Luo, PhD
• Ashutosh Mangalam, PhD
• Osorio Lopes Abath Neto, MD, PhD
• Mrutyunjaya Parida, PhD
• Shaelish Shahi, PhD
• Wen Wen, PhD
• Zuohui Zhang, MD, PhD

• Clinical and Pathologic features of 535 Patients with Congenital Mesoblastic Nephroma: A Report from the Children's Oncology Group. Davick JJ, Renfro LA, Cost NG, Aldrink JH, Geller JI, Khanna G, Ehrlich PF, Fernandez CV, Dome JS, Perlman EJ, Mullen EA; AREN03B2 Authorship Group. Ann Surg. 2025 Aug 1. doi: 10.1097/SLA.0000000000006862. Online ahead of print. PMID: 40747894
   

• Cell type differences in human cytomegalovirus transcription and epigenetic regulation with insights into major immediate-early enhancer-promoter control. Hu Q, Li M, Parida M, Spector BM, Santana JF, Zandvakili A, Price DH, Meier JL. PLoS Pathog. 2025 Aug 4;21(8):e1013374. doi: 10.1371/journal.ppat.1013374. Online ahead of print. PMID: 40758707
   
• Effects of alcohol on gut microbiome in adolescent and adult MMTV-Wnt1 mice. Li H, Meza LA, Shahi SK, Zhang Z, Wen W, Hu D, Lin H, Mangalam AK, Luo J. Front Oncol. 2025 Jul 16;15:1557040. doi: 10.3389/fonc.2025.1557040. eCollection 2025. PMID: 40740867
   

• Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumors. Dampier CH, Shah N, Galbraith K, Ebrahimi A, Neto OLA, Abdullaev Z, Alexandrescu S, Andreiuolo F, Armstrong T, Baker T, Cathcart S, Chung HJ, Cimino PJ, Conway KS, Cotter J, Costa FD, Dazelle K, Etminam N, Ferman SE, Fernandes I, Ferrone CK, Gilani A, Gilbert M, Gregory J, Ketchum C, Lee HS, Lee I, Lopes MBS, Mao Q, Marshall MS, McCord M, Neill SG, Nirschl JJ, Ozer BH, Paulus W, Penas-Prado M, Prinz M, Pytel P, Quezado M, Raffeld M, Rajan S, Ratliff M, Reifenberger G, Robinson L, Schittenhelm J, Schrimpf D, Singh O, Thomas C, Thomas D, Thomas-Ogunniyi J, Toland A, Turakulov R, Vaubel R, Wadhwani N, Wu J, Giannini C, Snuderl M, Brandner S, von Deimling A, Aldape K. Neurooncol Adv. 2025 Jul 19;7(1):vdaf089. doi: 10.1093/noajnl/vdaf089. eCollection 2025 Jan-Dec. PMID: 40735274